Antibiotics are used only when removal of prosthesis isn’t possible. Treatment of Stenotrophomonas Maltophilia Infection. Stenotrophomonas maltophilia is a bacteria which is resistant to several antibiotics. Tigecycline may potentially be helpful, but clinical investigation is needed. INTRODUCTION. 50 … Code: 120; Updated: January 29, 2020; Background. Most cases of infection tends to occur through use of hospital appliances such as catheters, I.V lines and breathing tubes in immunocompromised people. Administration of an antibiotic against S. maltophilia had no effect on outcomes c. Concomitant nosocomial pathogens were present in >30% of patients 3. Stenotrophomonas maltophilia has emerged as an important nosocomial pathogen capable of causing respiratory, bloodstream, and urinary infections. Stenotrophomonas maltophilia: Introduction. The most effective treatment involves the removal of prosthetic devices. The treatment of nosocomial infections by S. maltophilia is difficult, as this pathogen shows high levels of intrinsic or acquired resistance to different antimicrobial agents, drastically reducing the antibiotic options available for treatment. Stenotrophomonas maltophilia (SM) is one of the most common emerging gram – negative micro-organisms found in the sputum colture of people with cystic fibrosis and its prevalence is increasing (Hatziagorou E, 2019). maltophilia is found mostly in wet environments. Chronic infection with Stenotrophomonas maltophilia has recently been shown to be an independent predictor of pulmonary exacerbation requiring hospitalization and antibiotics. It is an opportunistic pathogen with high morbidity and high mortality rate among hospitalised patients. Stenotrophomonas maltophilia (S. maltophilia) infection is a type of bacterial infection.S. However, the role of antibiotic treatment of Stenotrophomonas maltophilia infection in people with cystic fibrosis is still unclear. Microbiology. Chronic infection with Stenotrophomonas maltophilia has recently been shown to be an independent predictor of pulmonary exacerbation requiring hospitalization and antibiotics. As mentioned earlier, Stenotrophomonas maltophilia is very difficult to treat due to its natural resistance to many antibiotics.

Chronic infection with Stenotrophomonas maltophilia has recently been shown to be an independent predictor of pulmonary exacerbation requiring hospitalization and antibiotics. Background. Stenotrophomonas maltophilia has emerged as an important nosocomial pathogen capable of causing respiratory, bloodstream, and urinary infections. [17, 18] S maltophilia is consistently susceptible to trimethoprim-sulfamethoxazole (TMP-SMZ).